Please register or login to view the chart

Methotrexate- Monitoring

A guide to monitoring methotrexate prescribing in primary care.Folic acid antagonist – antimetabolite cytotoxic agent Inhibits dihydrofolate reductase – prevents DNA and RNA synthesis Anti-inflammatory effect Immunosuppressive action Tablets of 2.5 mg strength – once weekly Metoject® 7.5 mg , 10 mg , 12.5 mg , 15 mg , 17.5 mg , 20 mg , 22.5 mg and 25 mg Oral solution Folic acid @ 5 mg is given ( separate day to MTX ) to reduce SEs

Indications – Disease modifying agent
 Wide range of neoplastic conditions such as
○ leukaemias
○ Non-Hodgkins’s lymphoma
○ soft-tissue and osteogenic sarcomas
○ solid tumours particularly breast , lung , head and neck , bladder , cervical , ovarian and testicular tumours Psoriasis and psoriatic arthritis ( severe )
 First line in active rheumatoid arthritis or
○ In combination with other DMARDSs for e.g sulfasalazine , leflunomide or hydroxychloroquine
○ parenteral – s/c or im
 Neurology for conditions as
○ myasthenia gravis
○ inflammatory myopathies and neuropathies
○ vasculitis
○ other immune mediated CNS and PNS system diseases
 Inflammatory bowel disease e.g Crohn’s
( NICE recommends not to use for ulcerative colitis unless no other alternative )
 Interstitial lung disease , sarcoidosis and pulmonary vasculitis
 Scleritis ,vasculitis or mixed connective tissue diseases

side effects

Mucosal damage Nausea , vomiting , anorexia Ulcerative stomatitis- may be the first sign of GI toxicity Affects gametogenensis – ↓ fertility. Bone marrow suppression Hepatotoxicity Pulmonary toxicity – methotrexate pneumonitis

Contraindications –Pregnancy- teratogenic Breast feeding Severe renal impairment Significant hepatic impairment Blood disorders e.g untreated folate deficiency , leucopenia , thrombocytopenia , bone marrow hypoplasia or significant anaemia Alcoholism Severe acute or chronic infections and immunodeficiency syndrome Stomatitis , ulcers of the oral cavity and known gastrointestinal ulcer disease Hypersensitivity to methotrexate No live vaccinations should be used during methotrexate treatment Avoid using other antifolate medications with methotrexate

drug interactions –Phenytoin ( ↑ ed anti-folate effect of methotrexate) Probenecid , Penicllin , NSAIDs ( ↓ ed methotrexate excretion ↑ed levels 
Sig interaction between NSAIDS and methotrexate rare Tolbutamide ( ↑ serum conc of methotrexate ) Trimethoprim , Co-trimaxazole ( ↑ ed antifolate effect of methotrexate greatly increasing the risk of marrow aplasia ) Clozapine ( ↑ed risk of agranulocytosis) Ciprofloxacin (reduced excretion ↑ ed risk of toxicity- Monitor) Topical fluorouracil (toxic skin reaction) Neomycin oral ( ↓ ed levels of methotrexate ) Tetracycline / Doxycycline ( ↑ ed ed risk of toxicity )

FBC , U-Es and LFT-Every 2 weeks until dose is stable for 6 weeks Then monthly for 3 months Thereafter atleast every 12 weeks

More frequent monitoring is appropriate in patients at higher risk of toxicity


  1. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis M Cutolo , A Sulli , C pizzorni , B Seriolo Ann Rheum Dis 2001;60:729-735 doi:10.1136/ard.60.8.729
  2. An update on Methotrexate accessed via
  3. Medicine Compendium accessed via
  4. Gwent Shared Care Protocol ; Oral Methotrexate for adults with Rheumatoid Arthritis ( RA ) , Psoriasis and Inflammatory Bowel Disease
  5. CKS NHS DMARDs accessed via!scenario:8
  6. The Top 100 Drugs – Andrew Hitchings , Dagan Lonsdale , Daniel Burrage , Emma Baker
  7. Rapid Clinical Pharmacology – Andrew Batchelder , Charlene Rodrigues , Ziad Alfrifai
  8. Oxford University Hospital NHS Trust -Clinical Commissioning Group- Methotrexate July 2015
  9. Basingstoke Southampton & Winchester District Prescribing Committee – Shared Care Guideline for Methotrexate 
GP Summary


Related Charts:

Add Your Comments

Your email address will not be published.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

A4 Medicine  - Search Less and Learn More

Welcome to the A4 medicine community where we are constantly working to provide exceptional educational material to primary health care professionals. Subscribe to our website for complete access to our A4 Charts. They are aesthetically designed charts that contain 300 (plus and adding) common and complex medical conditions with the all information required for primary care in one single page that can help you in consultation/practice and exam.

Additionally, you will get complete access for our Learn From Experts : A4 Webinar Series in which domain experts share the video explainer presentation on one medical condition in one hour for the primary care. And you will also get a hefty discount on our publications and upcoming digital products.

We are giving a lifetime flat 30% discount to our first thousand users, discount code already applied to checkout.